Obstetric outcomes associated with infection by Mycoplasma hominis and/or Mycoplasma genitalium.
DOI:
https://doi.org/10.52611/confluencia.num1.2023.916Keywords:
Pregnancy, Reproductive Tract Infections, Mycoplasma InfectionsAbstract
Introduction: Over the last 10 years, the introduction of new techniques for detecting microorganisms involved in genital tract infections in pregnant women has raised questions among healthcare teams about their association with adverse obstetric events, such as premature birth, premature rupture of membranes, spontaneous abortion, among others, and, based on this, how to manage the presence of these infections during pregnancy. Objective: To identify the association between the presence of Mycoplasma genitalium and/or Mycoplasma hominis infection and adverse obstetric outcomes in order to guide healthcare professionals on the need to treat pregnant women with infection. Methodology: A search was conducted for articles published in Pubmed and Scielo between 2013 and 2023. Development: Evidence was found in favour of an association between infection with Mycoplasma genitalium and/or Mycoplasma hominis and premature birth, premature rupture of membranes, and low birth weight, but not with spontaneous abortion. Conclusion: Further studies are needed to categorically recommend screening and treatment for asymptomatic infection with Mycoplasma genitalium and/or Mycoplasma hominis in pregnancy.
References
Gómez Rufo D, García Sánchez E, García Sánchez JE, García Moro M. Implicaciones clínicas de las especies del género Mycoplasma [Clinical implications of the genus Mycoplasma]. Rev Esp Quimioter. 2021 Jun;34(3):169-84. Disponible en: https://doi.org/10.37201%2Freq%2F014.2021
Magdaleno. María Alejandra, Irurtia MC, Casanova NB, Leonino P, Pereyra A, Di Bartolomeo S, et al. Prevalencia de la infección por Mycoplasma genitalium en mujeres embarazadas [Internet]. Acta Bioquím Clín Latinoam 2020;54(4):415-20. Disponible en: http://www.scielo.org.ar/pdf/abcl/v54n4/0325-2957- ABCL-54-04-00415.pdf
Wiesenfeld HC, Manhart LE. Mycoplasma genitalium in women: Current knowledge and research priorities for this recently emerged pathogen. J Infect Dis [Internet]. 2017;216(suppl_2):S389-95. Disponible en: http://dx.doi.org/10.1093/infdis/jix198
Waltmann A, McKinnish TR, Duncan JA. Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges: Current controversies and new challenges. Curr Opin Infect Dis [Internet]. 2021;34(1):40-9. Disponible en: http://dx.doi.org/10.1097/QCO.0000000000000702
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. Prediction and prevention of spontaneous preterm birth: ACOG Practice Bulletin, number 234: ACOG practice bulletin, number 234. Obstet Gynecol [Internet]. 2021;138(2):e65-90. Disponible en: http://dx.doi.org/10.1097/AOG.0000000000004479
Frenzer C, Egli-Gany D, Vallely LM, Vallely AJ, Low N. Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis. Sex Transm Infect [Internet].
Infección por Ureaplasma urealyticum y/o Ureaplasma parvum: resultados obstétricos
;98(3):222-7. Disponible
http://dx.doi.org/10.1136/sextrans-2021-055352
en:
Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis [Internet]. 2015;61(3):418-26. Disponible en: http://dx.doi.org/10.1093/cid/civ312
Murtha AP, Edwards JM. The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin North Am [Internet]. 2014;41(4):615-27. Disponible en: http://dx.doi.org/10.1016/j.ogc.2014.08.010
MaC,DuJ,DouY,ChenR,LiY,ZhaoL,etal.The associations of genital mycoplasmas with female infertility and adverse pregnancy outcomes: A systematic review and meta-analysis. Reprod Sci [Internet]. 2021;28(11):3013-31. Disponible en: http://dx.doi.org/10.1007/s43032-020-00399-w
Kayem G, Doloy A, Schmitz T, Chitrit Y, Bouhanna P, Carbonne B, et al. Antibiotics for amniotic-fluid colonization by Ureaplasma and/or Mycoplasma spp. to prevent preterm birth: A randomized trial. PLoS One [Internet]. 2018;13(11):e0206290. Disponible en: http://dx.doi.org/10.1371/journal.pone.0206290
Ona S, Molina RL, Diouf K. Mycoplasma genitalium: An overlooked sexually transmitted pathogen in women? Infect Dis Obstet Gynecol [Internet]. 2016;2016:4513089. Disponible en: http://dx.doi.org/10.1155/2016/4513089
Kuba K, Bernstein PS. ACOG practice bulletin no. 188: Prelabor rupture of membranes. Obstet Gynecol [Internet]. 2018;131(6):1163-4. Disponible en: http://dx.doi.org/10.1097/AOG.0000000000002663 Jonduo ME, Vallely LM, Wand H, Sweeney EL, Egli- Gany D, Kaldor J, et al. Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum: a
systematic review and meta-analysis. BMJ Open [Internet]. 2022;12(8):e062990. Disponible en: http://dx.doi.org/10.1136/bmjopen-2022-062990
Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis [Internet]. 2013;26(3):231-40. Disponible en: http://dx.doi.org/10.1097/QCO.0b013e328360db58
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Confluencia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
